Information  X 
Enter a valid email address

Company Name matching 'BioNTech SE'

Date
Time Source
Company
Announcement
07 May 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
06 May 2021 11:30 am GNW   BioNTech SE Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
04 May 2021 12:02 pm GNW   BioNTech SE BioNTech to Report First Quarter 2021 Financial Results and Operational Update on May 10, 2021
30 Apr 2021 12:00 pm GNW   BioNTech SE Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
19 Apr 2021 9:00 am GNW   BioNTech SE Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
01 Apr 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
31 Mar 2021 11:45 am GNW   BioNTech SE Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
30 Mar 2021 11:30 am GNW   BioNTech SE BioNTech Announces Full Year 2020 Financial Results and Corporate Update
26 Mar 2021 1:45 pm GNW   BioNTech SE BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site
  1:20 pm GNW   BioNTech SE EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union
23 Mar 2021 11:00 am GNW   BioNTech SE BioNTech to Report Full Year Financial Results for 2020 and Provide Corporate Update on the Fourth Quarter on March 30, 2021
11 Mar 2021 11:45 am GNW   BioNTech SE Real-World Evidence Confirms High Effectiveness of Pfizer-BioNTech COVID-19 Vaccine and Profound Public Health Impact of Vaccination One Year After Pandemic Declared
25 Feb 2021 11:45 am GNW   BioNTech SE Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
19 Feb 2021 12:07 pm GNW   BioNTech SE Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
18 Feb 2021 6:30 pm GNW   BioNTech SE Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
17 Feb 2021 10:13 pm GNW   BioNTech SE In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
  9:00 am GNW   BioNTech SE Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
12 Feb 2021 1:30 pm GNW   BioNTech SE Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
10 Feb 2021 8:00 am GNW   BioNTech SE Update on vaccine production at BioNTech’s manufacturing site in Marburg
01 Feb 2021 1:32 pm GNW   BioNTech SE Pfizer and BioNTech Publish Preclinical Data from Investigational COVID-19 Vaccine Program in Nature
22 Jan 2021 5:00 pm GNW   BioNTech SE Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
20 Jan 2021 12:50 pm GNW   BioNTech SE Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
08 Jan 2021 10:45 am GNW   BioNTech SE An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
07 Jan 2021 7:15 pm GNW   BioNTech SE BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
05 Jan 2021 11:00 am GNW   BioNTech SE BioNTech to Present at the 39th Annual J.P. Morgan Healthcare Conference
29 Dec 2020 6:10 pm GNW   BioNTech SE Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
23 Dec 2020 12:44 pm GNW   BioNTech SE Correction: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
21 Dec 2020 7:10 pm GNW   BioNTech SE BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
  7:05 pm GNW   BioNTech SE Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
  2:17 pm GNW   BioNTech SE Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
16 Dec 2020 8:00 am GNW   BioNTech SE BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine
14 Dec 2020 11:00 am GNW   BioNTech SE Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
10 Dec 2020 11:50 pm GNW   BioNTech SE Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
  3:46 pm GNW   BioNTech SE Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
09 Dec 2020 4:03 pm GNW   BioNTech SE Pfizer and BioNTech Achieve Health Canada Authorization for Their Vaccine to Combat COVID-19
02 Dec 2020 8:32 am GNW   BioNTech SE BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
  7:05 am GNW   BioNTech SE Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19
01 Dec 2020 10:00 am GNW   BioNTech SE Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA
25 Nov 2020 12:45 pm GNW   BioNTech SE BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies
20 Nov 2020 11:45 am GNW   BioNTech SE Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine
11 Nov 2020 11:15 am GNW   BioNTech SE Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19
10 Nov 2020 12:15 pm GNW   BioNTech SE BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress
09 Nov 2020 11:45 am GNW   BioNTech SE Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
03 Nov 2020 2:00 pm GNW   BioNTech SE BioNTech to Report Third Quarter 2020 Financial Results and Operational Update on November 10, 2020
06 Oct 2020 10:01 am GNW   BioNTech SE BioNTech and Pfizer Initiate Rolling Submission to European Medicines Agency for SARS-CoV-2 Vaccine Candidate BNT162b2
17 Sep 2020 9:00 am GNW   BioNTech SE BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
15 Sep 2020 11:30 am GNW   BioNTech SE BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
09 Sep 2020 12:45 pm GNW   BioNTech SE Pfizer and BioNTech Announce Data From Preclinical Studies of mRNA-Based Vaccine Candidate Against COVID-19
  11:15 am GNW   BioNTech SE Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
08 Sep 2020 11:30 am GNW   BioNTech SE Biopharma Leaders Unite to Stand with Science
21 Aug 2020 1:16 am GNW   BioNTech SE Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
11 Aug 2020 11:03 am GNW   BioNTech SE BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress
06 Aug 2020 11:00 am GNW   BioNTech SE BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020
05 Aug 2020 1:00 pm GNW   BioNTech SE Pfizer and BioNTech to Supply Canada with their BNT162 mRNA-Based Vaccine Candidate
  9:30 am GNW   BioNTech SE BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
31 Jul 2020 10:15 am GNW   BioNTech SE Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate
  7:00 am GNW   BioNTech SE BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma
30 Jul 2020 8:00 am GNW   BioNTech SE BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature
27 Jul 2020 9:15 pm GNW   BioNTech SE BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares
23 Jul 2020 2:42 am GNW   BioNTech SE BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering


Company Announcements Archive »

 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t